China Universal Asset Management »

Immunovant shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $771k 31k 24.77
2024-09-30 $803k 28k 28.51
2024-06-30 $453k 17k 26.40
2024-03-31 $903k 28k 32.31
2023-12-31 $705k 17k 42.13
2023-09-30 $129k 3.4k 38.39
2023-06-30 $32k 1.7k 18.97
2023-03-31 $27k 1.8k 15.51
2022-12-31 $23k 1.3k 17.75
2022-09-30 $6.0k 1.1k 5.49

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Immunovant

FMR
Vanguard Group
Armistice Capital
BlackRock
Deep Track Capital
T. Rowe Price Investment Management
State Street Corporation
Alpine Partners VI
Perceptive Advisors
Baker Bros. Advisors
Geode Capital Management
Two Seas Capital
Viking Global Investors
Paradigm Biocapital Advisors
Pictet Asset Management Holding SA

View all funds holding Immunovant